Somalia faces diphtheria surge amid vaccine shortages and aid cuts
More than 1,600 cases, including 87 deaths, have been recorded, up from 838 cases and 56 deaths in all of 2024, said Hussein Abdukar Muhidin, the general director of Somalia's National Institute of Health.
Diphtheria, a bacterial disease that causes swollen glands, breathing problems and fever and mostly affects children, is preventable with a vaccine that became widely available in the mid-20th century.
Childhood immunisation rates in Somalia have improved over the past decade, but hundreds of thousands of children are still not fully vaccinated.
After fleeing fighting between government forces and Islamist militants in the central Somalia town of Ceeldheere three months ago, all four of Deka Mohamed Ali's children, none of whom was vaccinated, contracted diphtheria. Her 9-year-old daughter recovered, but her 8-year-old son died and two toddlers are now being treated at a hospital in the capital Mogadishu.
"My children got sick and I just stayed at home because I did not know it was diphtheria," she told Reuters from the bedside of her 3-year-old son Musa Abdullahi whose throat was swollen to the size of a lemon from the infection.
Health Minister Ali Haji Adam said the government had struggled to procure enough vaccines due to a global shortage and that U.S. aid cuts were making it difficult to distribute the doses it had.
Before President Donald Trump cut most foreign assistance earlier this year, the United States was the leading humanitarian donor to Somalia, whose health budget is almost entirely funded by donors.
"The U.S. aid cut terribly affected the health funds it used to provide to Somalia. Many health centres closed. Mobile vaccination teams that took vaccines to remote areas lost funding and now do not work," said Adam.
Muhidin separately echoed his comments about the closures.
Overall U.S. foreign assistance commitments to Somalia stand at $149 million for the fiscal year that ends on September 30, compared with $765 million in the previous fiscal year, according to U.S. government statistics.
"The United States continues to provide lifesaving foreign assistance in Somalia," a U.S. State Department spokesperson said when asked about the impact of its aid cuts in the country.
"America is the most generous nation in the world, and we urge other nations to dramatically increase their humanitarian efforts."
Aid group Save the Children said last month that the closure of hundreds of health clinics in Somalia this year due to foreign cuts has contributed to a doubling in the number of combined cases of diphtheria, measles, whooping cough, cholera and severe respiratory infections since mid-April.
Besides the U.S., Britain, France, Germany and other major Western donors are also cutting aid budgets.
Somalia's government has also faced criticism from doctors and human rights activists for its limited funding of the health sector. In 2024, it allocated 4.8% of its budget to health, down from 8.5% the previous year, Amnesty International said.
The health ministry did not respond to a question about that criticism. It has said it is planning to launch a vaccination drive but has not given details when.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
8 hours ago
- Daily Mail
Bride was so stressed on the run up to her wedding her face became paralyzed
A bride has revealed how the stress of planning her $50,000 wedding left her face paralysed. Kelly Stech, from Chicago, spent a year organising her dream wedding to her now-husband Benjamin Stech after getting engaged in July 2022. However, the week before the ceremony, Kelly began feeling under the weather, complaining of earache and pain when swallowing. The following day, Kelly woke up with painful, swollen blisters across her right ear, which urgent care doctors put down to the skin infection cellulitis. Over the next few days, Kelly's symptoms dramatically worsened as the right side of her face became completely paralyzed on the eve of her wedding. Devastated, Kelly refused to cancel her nuptials and was left distraught when she was unable to 'fully smile' in her wedding photos. Days after tying the knot on October 6th 2023, Kelly returned to hospital where doctors diagnosed her with Ramsay Hunt syndrome, a rare condition where shingles affects your facial nerve, causing weakness on one side of your face and sometimes hearing problems. Kelly, who works as a hairdresser, believes the disorder was brought on due to the strain of wedding planning over the last year - and is now urging other brides to keep their stress levels in check. Kelly said: 'Exactly a week before the wedding, I was starting to feel under the weather. The following day, at work I felt like I had an ear infection coming on. 'It hurt to swallow and I felt a popping sensation in my ear. 'I went to urgent care and they said it looked completely fine and there was no infection brewing. 'I woke up that Monday and my ear was completely swollen and blistered. I went back to urgent care and they put me on a steroid and antibiotic for cellulitis. 'I woke up the next day and the pain was worse. I was vomiting non-stop, I couldn't keep anything down. 'My whole body felt like it had been hit by a truck. Then I was laying on the couch later on and making silly faces on Snapchat and couldn't feel the right side of my face moving.' Kelly continued: '[The next day] when I went to smile, the right side of my face just wouldn't move like the left side would. 'My ear had blisters on them. I was full blown panicking and crying. The pressure on my ear felt like it was going to explode. 'I went back to urgent care and they transferred me to a hospital. We were supposed to be going to our rehearsal dinner that night.' Kelly rushed back to hospital where doctors told her she'd had an allergic reaction to an IV antibiotic that had caused Bell's Palsy - a temporary weakness of one side of the face. Despite her deteriorating health, Kelly opted to go ahead with the wedding the next day. However, she made the last minute decision to slash her ceremony guest list from 200 people to 50 members of her close friends and family. Kelly said: 'I barely slept the whole night. There was barely any movement in my mouth. 'I could smile without teeth but if I tried to smile with teeth, it was definitely crooked. 'I wanted to go ahead with the wedding either way. My makeup artist was so good at hiding my paralysis.' The real cause: Days after her wedding Kelly returned to hospital where doctors diagnosed her with Ramsay Hunt syndrome Kelly contiuned: 'During the ceremony, me and the bridesmaids switched sides so my right-side paralysis wasn't facing my guests. 'The middle of the day at the venue, my right eyelid just stopped working. 'I couldn't go around taking photos anymore, my eyelid was paralysed, I couldn't blink. 'I was holding a handkerchief up to my eye to keep it shut. Everybody kept saying "sorry you're going through this". 'I felt like it was the happiest day of my life but I didn't want people to think I looked miserable because I couldn't smile on my wedding day. 'I couldn't drink any alcohol. I was in so much pain and so tired.' Luckily, Kelly has since regained all the movement in her face but is now urging brides-to-be to try and avoid wedding planning stress. Kelly, who is currently eight months pregnant, said: 'It's hard to believe this happened. My wedding stress definitely caused this. 'The financial stress of it definitely takes a toll. 'We got to experience first-hand early on what 'in sickness and health' actually meant. 'I tell friends stressed about wedding planning, be grateful you're in this position and don't let it stress you out, you don't want to end up paralysed on your wedding day. 'Don't stress about your shoes or the weather.'
Reuters
10 hours ago
- Reuters
Fact Check: Statement from Namibian president rejecting Gates Foundation contraceptives trial is fake
Online claims that the Namibian president released a statement rejecting a proposal by the Gates Foundation to conduct trials of a contraceptive device are false. The claims followed an August 4 announcement, opens new tab by the Gates Foundation committing $2.5 billion to 'accelerate research and development on women's health' by 2030. This includes 'contraceptive innovation' and a focus on low- and middle-income countries, Reuters reported. An August 11 Facebook post, opens new tab attributed an 'official statement' to President Netumbo Nandi-Ndaitwah rejecting a supposed Gates Foundation proposal to conduct trials of a hormonal intrauterine device, designed to prevent pregnancy for up to eight years. 'Any attempt to hinder or suppress the growth of human potential in Namibia constitutes a grave injustice to our people and their future,' read the statement attributed to Nandi-Ndaitwah. TikTok posts, opens new tab made the same claim on August 12. On August 11, the X account linked to the Namibian presidency's official website labelled a screenshot, opens new tab of one of these posts as 'fake.' The presidency did not respond to Reuters' request for comment. The Gates Foundation told Reuters that it is 'not undertaking any H-IUD (hormonal intrauterine device) work in Namibia,' but that it does 'work with partners to expand access to trusted, voluntary options like H-IUDs in other countries.' The foundation added that the quote attributed to the president was 'fabricated,' saying that the presidency has 'dismissed the claims as unfounded,' referring to the post by the presidency's X account. Reuters found no statement rejecting any such trials published on the Namibian presidency's official website or associated social media channels. False. The Namibian president did not publicly reject a proposal by the Gates Foundation to conduct contraceptive trials. No such trial is taking place in Namibia, and the presidency said a statement attributed to Netumbo Nandi-Ndaitwah was fake. This article was produced by the Reuters Fact Check team. Read more about our fact-checking work.
Reuters
11 hours ago
- Reuters
Health Rounds: Human fetal kidney development mimicked in test tubes
Aug 20 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up here. Researchers are a step closer to learning how congenital kidney defects develop in the fetus and how they might be prevented, a new report shows. For the first time, they can watch miniature human fetal kidneys develop in test tubes over periods that simulate the course of a pregnancy. So-called kidney organoids have been grown in test tubes before, but only starting with pluripotent stem cells – immature cells found in early embryos that can differentiate into any cell type in the body but without the tissue-specific characteristics that would allow them to perform an organ's specialized functions. In contrast, the new organoids are grown in test tubes using the same fetal progenitor stem cells that are destined to develop into human kidneys. These cells are capable of building, maintaining and repairing specific organs – in this case, the kidneys. While kidney organoids grown from pluripotent stem cells have survived in test tubes for weeks, the new organoids built from the human fetal kidney stem cells can survive and grow for six to eight months, essentially allowing researchers to observe human kidney development as it would happen during a pregnancy, the research team reported in The EMBO Journal, opens new tab. 'Once we had the tissue stem cells coming from the developing human kidney in the Petri dish, they did the job because this is what they do in nature,' said Dr. Benjamin Dekel of Safra Children's Hospital at Sheba Medical Center and Tel Aviv University, who led the research. 'The cells are self-assembling. They know how to self-organize and how to self-renew, (that is) make copies of themselves,' Dekel said. At the same time, Dekel continued, the cells begin to differentiate, developing qualities that make them appropriate for different roles. Researchers can watch as kidney tubules, ducts, blood vessels and other renal tissues are formed. In his clinical practice, Dekel treats children with kidney diseases. He hopes eventually to use the organoids to study kidney malformations and to isolate genes that lead to birth defects, develop new treatments in the field of regenerative medicine and test the toxicity of drugs during pregnancy on fetal kidneys. In the meantime, he said, it's frustrating to watch as patients' chronic kidney disease worsen into end-stage renal disease. 'Then we need to give them a kidney transplant or to put them on dialysis, which is really a very poor solution,' he said. New findings help explain why experimental treatments for cancers caused by human papillomavirus infections have been less than effective, researchers say. The most common cancer-causing strain of HPV undermines the body's defenses by reprogramming immune cells surrounding the tumor, earlier research has shown. Blocking this process can boost the ability of experimental treatments for HPV to eliminate cancer cells, according to a report published in the Journal for ImmunoTherapy of Cancer, opens new tab. While vaccines exist to prevent HPV infections, researchers have failed to develop effective 'therapeutic vaccines' for use after HPV infections have occurred – and the new study helps explain why. Experimental therapeutic vaccines target HPV-infected cells with immune cells known as T-cells. But in tests in mice and cell cultures, researchers found that two HPV proteins, E6 and E7, prompt nearby cells to release a protein called IL-23 that prevents the body's T-cells from attacking the tumor. 'In order to eliminate the cancer, T-cells need to proliferate and destroy infected cells. But IL-23 stops them from working effectively, so the tumor keeps growing,' study leader W. Martin Kast of the Keck School of Medicine of the University of Southern California said in a statement. Drugs that inhibit IL-23 are already approved for treating psoriasis and other conditions, the researchers said. 'The fact that these antibodies are already FDA-approved for something else makes this approach promising — and it also allows for rapid translation into the clinic,' Kast said. He and his team are now developing their own therapeutic vaccine, which they will test in combination with antibodies that block IL-23. IL-23 is also found at high levels in testicular and bladder cancers, the researchers noted, adding that further research is needed to clarify what role IL-23 plays in those diseases. Hearing loss is a known risk factor for dementia, but early intervention might lower that risk, a new study suggests. Researchers performed hearing tests in nearly 3,000 volunteers without dementia who were at least 60 years old. Over the next 20 years, the researchers saw a 61% lower risk for eventual dementia among those with newly diagnosed hearing loss who started wearing hearing aids before age 70, compared to participants diagnosed with hearing impairment at a similar age who did not get hearing aids, they reported in JAMA Neurology, opens new tab. Hearing aid use did not appear to protect against dementia in people diagnosed with a hearing problem after age 70, however. 'Only 17% of individuals with moderate to severe hearing loss use hearing aids,' the researchers noted. 'Our study underscores the importance of early intervention' to reduce the risk of dementia associated with hearing loss, they concluded. To receive the full newsletter in your inbox for free sign up here.
